Inventiva S.A. Sponsored ADR

IVA Healthcare Biotechnology

Inventiva S.A. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, down 43.7% from fiscal 2024.

2.94 0.17 −5.47%
Market cap
$740.0M
P/E
0.0×
Fwd P/E
−4.6×
Dividend yield
—
F-score
4/9
Altman Z
−1.36
Beneish M
−7.91
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
26.18 71.15 65.16 40.14 120.73 102.40 91.39 29.13 104.49 112.36
Receivables
15.08 8.27 15.34 11.02 10.37 9.91 6.33 9.91 5.92 4.86
Inventory
0.50 0.57 0.47 0.43 0.37 0.46 0.39 0.45 — —
Other current assets
1.67 1.01 1.36 3.15 20.46 23.97 13.98 12.66 10.25 159.37
Total current assets
43.42 80.99 82.34 54.74 151.92 136.74 112.09 52.16 120.67 276.59
Property, Plant, Equpment (Net)
5.22 5.44 4.90 4.17 3.75 3.78 7.78 9.88 5.42 3.37
Long-Term Investments
0.41 — — — — — — 1.54 1.23 0.60
Goodwill and Intangible Assets (Total)
2.18 2.18 1.77 1.38 1.07 0.91 0.60 0.59 0.05 0.21
Long Term Assets (Tax, Deferred)
— — — — — — — 0.24 0.23 0.22
Long-term assets (Other)
— 0.29 0.13 3.51 1.95 2.89 1.76 10.88 1.13 1.31
Total non-current assets
— — — 9.05 6.77 7.58 10.14 23.13 8.07 5.70
Total Assets
51.43 — 91.74 63.80 158.69 144.32 122.22 75.29 128.73 282.30
Accounts Payable
4.59 6.48 9.62 8.39 7.91 17.28 20.40 40.78 35.56 29.44
Current Part of Debt
0.15 0.32 0.17 0.13 0.02 1.52 6.16 5.74 6.35 36.55
Other current liabilities
4.10 3.54 6.88 7.01 7.96 8.25 5.79 7.76 88.73 21.56
Total current liabilities
9.05 10.86 17.34 15.53 15.89 27.04 32.35 54.29 130.64 87.55
Long Term Debt (Total)
0.51 0.27 0.09 0.00 11.47 10.46 30.20 34.83 52.44 31.17
Non-current Revenue (Deferred)
— 2.28 1.92 — — — — — — —
Long Term Tax Liability (Deferred)
2.97 (0.30) — — — — — — — —
Non-current Liabilities (Other)
1.10 1.62 1.59 1.91 4.30 1.69 11.76 20.84 61.06 195.85
Total non-current liabilities
— — — 1.91 15.76 12.15 41.96 55.67 113.49 227.02
Total liabilities
13.83 15.03 20.94 17.44 31.65 39.18 74.31 109.95 244.14 314.57
Additional Paid In Capital
— — — 96.33 159.54 195.30 183.21 218.48 269.62 597.64
Common Stock (Net)
0.11 0.20 0.26 0.30 0.44 0.48 0.44 0.56 1.04 2.19
Retained Earnings
(7.42) — — (33.84) (38.40) (58.72) (57.18) (119.51) (199.34) (400.67)
Shareholders Equity (Other)
— — — (16.43) 5.46 (31.92) (78.55) (134.19) (186.72) (231.42)
Common Equity (Total)
37.60 74.57 70.80 46.36 127.04 105.14 47.91 (34.67) (115.40) (32.27)
Shareholders Equity (Total)
37.60 74.57 70.80 46.36 127.04 105.14 47.91 (34.67) (115.40) (32.27)
Shareholders Equity and Liabilities (Total)
— — — 63.80 158.69 144.32 122.22 75.29 128.73 282.30
Shares (Common)
— — — 38.17 38.63 40.87 42.13 52.12 95.66 193.24
Shareholders Equity (Tangible)
— — — 44.98 125.97 104.23 47.31 (35.25) (115.45) (32.48)
Net Debt
(25.52) (70.57) (64.90) (40.01) (109.24) (90.43) (55.02) 11.44 (45.70) (44.64)
Total Debt
0.66 0.58 0.26 0.13 11.49 11.97 36.36 40.57 58.79 67.73

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 30 Sep 2026